AdobeStock_194352867_edited.jpg
WOUND+
Current Turnaround: 24-Hours

Wound Infection Testing

 

Chronic wounds are a challenge to professionals and consume a great deal of healthcare resources. Chronic wounds have a complex pathophysiology and contain polymicrobial infections existing as a cooperative community that is resistant to antibiotic therapies. Healthcare providers have relied on conventional culture methods which fail to provide an accurate diagnosis of the microbial interactions or representation of microorganism within a wound. 

 

Fast Track Treatments

Patients Choice WOUND+ test delivers advanced DNA analysis using Real-Time PCR technology, providing absolute identification of microorganisms within 24-hours. The WOUND+ test provides insight into microorganisms contributing to polymicrobial infection, quantification, and resistance gene identification with custom treatment recommendations leading to increased patient outcomes and lower healthcare costs.

This State-of-the-art technology and Antimicrobial Stewardship Program aims to improve the effectiveness of antimicrobial treatment and patient outcomes by proving physicians with the tools they need to optimize the use of advanced diagnostics. 

Become a Client Background-01-01.png

Patients Choice Advantage

  • Same-day results from when the sample arrives at the lab.

  • Changes the way infections are diagnosed and treated by identifying microbes by their DNA.
     

  • Molecular technology can find and identify polymicrobial infections.
     

  • Faster more accurate results, allowing physicians to act sooner and with more precision than ever.
     

  • Identification of resistant genes so that targeted therapy can be implemented from the onset of diagnosis.
     

  • Ability to detect bacterial and fungal microbes, many that are viable-but-nonculturable. 

  • Partnered with world-class PharmD group for personalized treatment recommendations

acinetobacter.png

CARBAPENEM-RESISTANT

ACINETOBACTER

Treat Level.png

8,500

Estimated cases of
hospitalized patients in 2017

700

Estimated deaths in 2017

$281M

Estimated attributable
healthcare costs in 2017

Nearly all carbapenem-resistant Acinetobacter infections happen in patients who recently received care in a healthcare facility and can cause wound, bloodstream, and urinary tract infections. Some Acinetobacter are resistant to nearly all antibiotics.3  

Icon.png
Icon.png
Icon.png

Diabetic foot wound infections are often resistant to traditional antimicrobial treatments and, due to the immunocompromised nature of such individuals, can actually increase the risk of certain infections.¹ 

Pressure ulcers can be a major source of infection and lead to many other complications. 2.5 million people are treated for pressure ulcers in acute care facilities in the US alone.2

A death every 15 minutes.
In 2019, 2.8 millions infections and 35,000 deaths in the United States alone, were caused by antibiotic-resistance bacteria and fungi.
4 This number could exceed 10 million people worldwide by 2050 if more isn’t done to stem antibiotic resistance.5